LEP and hypertriglyceridemia: In contrast to obesity-related metabolic abnormalities, lipodystrophy is associated with a lack of leptin and leptin replacement therapy has been shown to improve insulin resistance and hypertriglyceridemia in patients with lipodystrophy.